1. Torre, LA, Bray, F, Siegel, RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
Google Scholar | Crossref | Medline | ISI2. Chen, W, Zheng, R, Zeng, H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res 2015; 27: 2–12.
Google Scholar | Crossref | Medline3. Van Cutsem, E, Nordlinger, B, Cervantes, A, et al. Advanced colorectal cancer: eSMO clinical practice guidelines for treatment. Ann Oncol 2010; 21: v93–v97.
Google Scholar | Crossref | Medline | ISI4. Compton, CC . Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003; 16: 376–388.
Google Scholar | Crossref | Medline | ISI5. Zlobec, I, Lugli, A. Prognostic and predictive factors in colorectal cancer. J Clin Pathol 2008; 61: 561–569.
Google Scholar | Medline | ISI6. Stocker, R, Yamamoto, Y, McDonagh, AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043–1046.
Google Scholar | Crossref | Medline | ISI7. Vitek, L, Schwertner, HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1–57.
Google Scholar | Crossref | Medline | ISI8. Marnett, LJ . Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361–370.
Google Scholar | Crossref | Medline | ISI9. Di Giacomo, C, Acquaviva, R, Lanteri, R, et al. Nonproteic antioxidant status in plasma of subjects with colon cancer. Exp Biol Med (Maywood 2003; 228: 525–528.
Google Scholar | SAGE Journals | ISI10. Ching, S, Ingram, D, Hahnel, R, et al. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J Nutr 2002; 132: 303–306.
Google Scholar | Crossref | Medline11. Horsfall, LJ, Rait, G, Walters, K, et al. Serum bilirubin and risk of respiratory disease and death. JAMA 2011; 305: 691–697.
Google Scholar | Crossref | Medline12. Wen, CP, Zhang, F, Liang, D, et al. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res 2015; 21: 193–200.
Google Scholar | Crossref | Medline13. Zucker, SD, Horn, PS, Sherman, KE. Serum bilirubin levels in the U.S. Population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004; 40: 827–835.
Google Scholar | Crossref | Medline | ISI14. Vitek, L, Ostrow, J. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des 2009; 15: 2869–2883.
Google Scholar | Crossref | Medline | ISI15. Jiraskova, A, Novotny, J, Novotny, L, et al. Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer 2012; 131: 1549–1555.
Google Scholar | Crossref | Medline16. Xu, C, Tang, X, Qu, Y, et al. UGT1A1 Gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer. Cancer Chemother Pharmacol 2016; 78: 119–130.
Google Scholar | Crossref | Medline17. Liu, X, Cheng, D, Kuang, Q, et al. Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. Pharmacogenomics J 2014; 14: 120–129.
Google Scholar | Crossref | Medline | ISI18. Xie, FW, Peng, YH, Wang, WW, et al. Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11. Biomed Pharmacother 2014; 68: 825–831.
Google Scholar | Crossref | Medline19. Gagnon, JF, Bernard, O, Villeneuve, L, et al. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Clin Cancer Res 2006; 12: 1850–1858.
Google Scholar | Crossref | Medline | ISI20. Liu, X, Meng, QH, Ye, Y, et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 2015; 36: 243–248.
Google Scholar | Crossref | Medline21. Li, N, Xu, M, Cai, MY, et al. Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer. Cancer Epidemiol 2015; 39: 763–768.
Google Scholar | Crossref | Medline22. Deng, CC, Xu, M, Li, J, et al. Unconjugated bilirubin is a novel prognostic biomarker for nasopharyngeal carcinoma and inhibits its metastasis via antioxidation activity. Cancer Prev Res (Phila) 2016; 9: 180–188.
Google Scholar | Crossref | Medline23. Gao, C, Fang, L, Li, JT, et al. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients. World J Gastroenterol 2016; 22: 2576–2584.
Google Scholar | Crossref | Medline24. Zhang, Q, Ma, X, Xu, Q, et al. Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection. Oncotarget 2016; 8: 71138–71146.
Google Scholar | Crossref | Medline25. Camp, RL, Dolled-Filhart, M, Rimm, DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10: 7252–7259.
Google Scholar | Crossref | Medline | ISI26. Altman, DG, Vergouwe, Y, Royston, P, et al. Prognosis and prognostic research: validating a prognostic model. Br Med J 2009; 338: b605.
Google Scholar | Crossref | Medline27. Wang, Y, Li, J, Xia, Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013; 31: 1188–1195.
Google Scholar | Crossref | Medline | ISI28. Chambless, LE, Cummiskey, CP, Cui, G. Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med 2011; 30: 22–38.
Google Scholar | Crossref | Medline | ISI29. Keshavan, P, Schwemberger, SJ, Smith, DL, et al. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer 2004; 112: 433–445.
Google Scholar | Crossref | Medline30. Lin, JP, Vitek, L, Schwertner, HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010; 56: 1535–1543.
Google Scholar | Crossref | Medline | ISI